Skip to main content

Advertisement

SpringerLink
Log in

Decreased heart rate variability in patients with psoriatic arthritis

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The purpose of this study was to investigate autonomous regulation of the cardiac activity by means of the heart rate variability (HRV) assessment and possible influence of conventional cardiovascular risk factors and disease activity parameters on it in patients with psoriatic arthritis (PsA). In total, 38 patients with the reliable diagnosis of PsA without clinically manifest cardiovascular pathology, known rhythm or conduction disturbances, diabetes mellitus, and hypercholesterolemia were included. In the control group, 25 age- and sex-matched healthy persons comparable with PsA patients in cardiovascular risk profile were included. For the HRV analysis, we used 5-min-long ECG records obtained at rest. Time and frequency domain parameters of HRV were calculated. Patients with PsA had decreased HRV in comparison to healthy controls as reflected by decrease of the standard deviation of normal R-R intervals (65.1 ± 66.8 vs. 83.2 ± 43.3 ms, respectively, p = 0.011), of the percentage of normal R-R intervals that differ by more than 50 ms (12.9 ± 15.4 vs. 20.6 ± 17.1 %, respectively, p = 0.035), and of the total power (2,069.4 ± 1,537.8 vs. 2,942.5 ± 1,734.2 ms2, respectively, p = 0.006). A significant correlation of HRV parameters with disease duration and parameters of disease activity in PsA was found. Patients with PsA had impaired autonomous regulation of the cardiac activity, which is likely to be related to the presence of systemic inflammation and which could contribute to the increase of cardiovascular risk in this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE (2000) The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 27(5):1247–1250

    PubMed  CAS  Google Scholar 

  2. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53(4):573

    Article  PubMed  Google Scholar 

  3. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61(2):233–239

    Article  PubMed  CAS  Google Scholar 

  4. Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41(6):1103–1110. doi:10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N

    Article  PubMed  CAS  Google Scholar 

  5. Wong K, Gladman DD, Husted J, Long JA, Farewell VT (1997) Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 40(10):1868–1872. doi:10.1002/1529-0131(199710)40:10<1868::AID-ART21>3.0.CO;2-W

    Article  PubMed  CAS  Google Scholar 

  6. Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT (2009) Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 68(7):1131–1135. doi:10.1136/ard.2008.094839

    Article  PubMed  CAS  Google Scholar 

  7. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33(11):2167–2172

    PubMed  Google Scholar 

  8. Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, Bitterman H, Feld J, Rimar D, Rosner I (2008) Subclinical atherosclerosis in psoriatic arthritis: a case–control study. J Rheumatol 35(5):877–882

    PubMed  Google Scholar 

  9. Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, Ohman ML, Rantapaa-Dahlqvist S, Wallberg-Jonsson S (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 13(4):R131. doi:10.1186/ar3442

    Article  PubMed  Google Scholar 

  10. Bengtsson C, Ohman ML, Nived O, Rantapaa Dahlqvist S (2011) Cardiovascular event in systemic lupus erythematosus in northern Sweden—incidence and predictors in a 7-year follow up study. Lupus. doi:10.1177/0961203311425524

  11. Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J (2011) Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 27(2):174–182. doi:10.1016/j.cjca.2010.12.040

    Article  PubMed  Google Scholar 

  12. Khan F, Galarraga B, Belch JJ (2010) The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 6(5):253–261. doi:10.1038/nrrheum.2010.44

    Article  PubMed  Google Scholar 

  13. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF (2004) Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25(5):363–370

    Article  PubMed  Google Scholar 

  14. Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13(3–4):178–184

    PubMed  Google Scholar 

  15. Madsen T, Christensen JH, Toft E, Schmidt EB (2007) C-reactive protein is associated with heart rate variability. Ann Noninvasive Electrocardiol 12(3):216–222

    Article  PubMed  Google Scholar 

  16. Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F, Goldberg J, Vaccarino V (2008) Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 156(4):759, e751-757

    Article  PubMed  Google Scholar 

  17. de Bruyne MC, Kors JA, Hoes AW, Klootwijk P, Dekker JM, Hofman A, van Bemmel JH, Grobbee DE (1999) Both decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: the Rotterdam Study. Am J Epidemiol 150(12):1282–1288

    Article  PubMed  Google Scholar 

  18. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG (2000) Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 102(11):1239–1244

    Article  PubMed  CAS  Google Scholar 

  19. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Hansen JF (2006) C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J Intern Med 260(4):377–387

    Article  PubMed  CAS  Google Scholar 

  20. Evrengul H, Dursunoglu D, Cobankara V, Polat B, Seleci D, Kabukcu S, Kaftan A, Semiz E, Kilic M (2004) Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 24(4):198–202. doi:10.1007/s00296-003-0357-5

    Article  PubMed  Google Scholar 

  21. Kaya EB, Okutucu S, Aksoy H, Karakulak UN, Tulumen E, Ozdemir O, Inanici F, Aytemir K, Kabakci G, Tokgozoglu L, Ozkutlu H, Oto A (2010) Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability. Clin Res Cardiol: Off J German Card Soc 99(12):803–808. doi:10.1007/s00392-010-0187-x

    Google Scholar 

  22. Poddubnyi DA, Gaidukova IZ, Rebrov AP (2009) Heart rate variability in patients with ankylosing spondilitis (Bekhterev’s disease). Ter Arkh 81(6):56–62

    PubMed  CAS  Google Scholar 

  23. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673

    Article  PubMed  Google Scholar 

  24. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R, van ver Tempel H, Mielants H, Dougados M, van der Heijde D (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127–132

    Article  PubMed  CAS  Google Scholar 

  25. van der Heijde DM, van’t Hof M, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20(3):579–581

    PubMed  Google Scholar 

  26. Poddubnyy DA, Rudwaleit M, Listing J, Braun J, Sieper J (2010) Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis 69(7):1338–1341

    Article  PubMed  CAS  Google Scholar 

  27. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359(9313):1173–1177. doi:10.1016/S0140-6736(02)08213-2

    Article  PubMed  CAS  Google Scholar 

  28. van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8(5):R151. doi:10.1186/ar2045

    Article  PubMed  Google Scholar 

  29. Carmona L, Descalzo MA, Perez-Pampin E, Ruiz-Montesinos D, Erra A, Cobo T, Gomez-Reino JJ (2007) All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Ann Rheum Dis 66(7):880–885. doi:10.1136/ard.2006.067660

    Article  PubMed  CAS  Google Scholar 

  30. Dixon WG, Watson KD, Lunt M, Hyrich KL, Silman AJ, Symmons DP (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56(9):2905–2912. doi:10.1002/art.22809

    Article  PubMed  CAS  Google Scholar 

  31. Da Silva JA, Jacobs JW, Kirwan JR, Boers M, Saag KG, Ines LB, de Koning EJ, Buttgereit F, Cutolo M, Capell H, Rau R, Bijlsma JW (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 65(3):285–293. doi:10.1136/ard.2005.038638

    Article  PubMed  Google Scholar 

  32. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331. doi:10.1136/ard.2009.113696

    Article  PubMed  CAS  Google Scholar 

  33. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332(7553):1302–1308. doi:10.1136/bmj.332.7553.1302

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Hospital Therapy, Saratov State Medical University, Saratov, Russia

    Inna Gaydukova, Andrey Rebrov & Natalia Nikitina

  2. Rheumatology, Med. Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Germany

    Denis Poddubnyy

Authors
  1. Inna Gaydukova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrey Rebrov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Natalia Nikitina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Denis Poddubnyy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Denis Poddubnyy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaydukova, I., Rebrov, A., Nikitina, N. et al. Decreased heart rate variability in patients with psoriatic arthritis. Clin Rheumatol 31, 1377–1381 (2012). https://doi.org/10.1007/s10067-012-2015-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-2015-3

Keywords

Search

Navigation